WINDTREE THERAPEUTICS INC /DE/ Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Windtree Therapeutics Inc /De/ Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.75M, a 37.9% increase year-over-year.
  • Windtree Therapeutics Inc /De/ Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.71M, a 60.9% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Net Income (Loss) Attributable to Parent for 2023 was -$20.3M, a 48.2% increase from 2022.
  • Windtree Therapeutics Inc /De/ annual Net Income (Loss) Attributable to Parent for 2022 was -$39.2M, a 42% increase from 2021.
  • Windtree Therapeutics Inc /De/ annual Net Income (Loss) Attributable to Parent for 2021 was -$67.6M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.71M -$2.75M +$1.68M +37.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-26
Q2 2024 -$11.4M -$12M -$5.42M -82.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-26
Q1 2024 -$5.96M $10.2M +$14.3M Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-26
Q4 2023 -$20.3M -$5.15M +$4.54M +46.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$24.8M -$4.43M -$369K -9.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-26
Q2 2023 -$24.5M -$6.6M +$10.7M +61.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-26
Q1 2023 -$35.2M -$4.11M +$4.02M +49.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-26
Q4 2022 -$39.2M -$9.69M +$3.38M +25.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$42.6M -$4.06M +$4.16M +50.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$46.7M -$17.3M +$20.1M +53.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$66.8M -$8.13M +$834K +9.31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$67.6M -$13.1M -$5.62M -75.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$62M -$8.21M +$807K +8.95% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$62.8M -$37.4M -$27.8M -291% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$35M -$8.96M -$2.43M -37.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$32.6M -$7.45M -$79K -1.07% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$32.5M -$9.02M -$1.89M -26.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$30.6M -$9.56M -$3.12M -48.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$27.5M -$6.53M +$3K +0.05% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$27.5M -$7.38M +$1.67M +18.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-03
Q3 2019 -$29.1M -$7.13M -$3.2M -81.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$25.9M -$6.44M -$3.39M -111% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$22.6M -$6.54M -$2.03M -44.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$20.5M -$9.04M -$11.5M -466% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 -$9.02M -$3.93M +$1.52M +27.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-04-03
Q2 2018 -$10.5M -$3.05M +$3.7M +54.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-03
Q1 2018 -$14.2M -$4.51M +$4.21M +48.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-04-03
Q4 2017 -$18.4M $2.47M +$9.08M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 -$27.5M -$5.44M +$2.92M +34.9% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-04-23
Q2 2017 -$30.4M -$6.75M +$3.87M +36.4% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-04-23
Q1 2017 -$34.3M -$8.72M +$5.18M +37.2% Jan 1, 2017 Mar 31, 2017 10-K/A 2019-04-23
Q4 2016 -$39.5M -$6.6M +$3.51M +34.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$43M -$8.36M +$13.2M +61.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-17
Q2 2016 -$56.2M -$10.6M +$702K +6.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-17
Q1 2016 -$56.9M -$13.9M -$1.72M -14.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-17
Q4 2015 -$55.2M -$10.1M +$526K +4.95% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$55.7M -$21.6M -$10.2M -90.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$45.5M -$11.3M -$703K -6.62% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$44.8M -$12.2M -$703K -6.13% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
Q4 2014 -$44.1M -$10.6M +$1.09M +9.33% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 -$45.2M -$11.3M +$900K +7.36% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-03-29
Q2 2014 -$46.1M -$10.6M -$2M -23.1% Apr 1, 2014 Jun 30, 2014 10-K/A 2016-03-29
Q1 2014 -$44.1M -$11.5M +$1.16M +9.17% Jan 1, 2014 Mar 31, 2014 10-K/A 2016-03-29
Q4 2013 -$45.2M -$11.7M -$4.91M -72.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$40.3M -$12.2M +$1.12M +8.41% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$41.4M -$8.63M -$1.49M -20.9% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$39.9M -$12.6M -$2.62M -26.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$37.3M -$6.82M -$2.51M -58.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$34.8M -$13.3M -$8.6M -181% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-17
Q2 2012 -$26.2M -$7.14M +$938K +11.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-17
Q1 2012 -$27.1M -$10M -$6.18M -161% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-17
Q4 2011 -$21M -$4.3M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$4.75M +$1.83M +27.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$8.08M -$7.28M -918% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$3.84M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$6.58M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$793K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.